On November 2, 2023 MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, reported that the Company’s management will participate in the following upcoming investor conferences (Press release, MacroGenics, NOV 2, 2023, View Source [SID1234636774]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BMO Biopharma Spotlight Series: Oncology Day
Date: Wednesday, November 8, 2023
Fireside Chat: 10:30 am ET
Location: Virtual

Stifel 2023 Healthcare Conference
Date: Tuesday, November 14, 2023
Fireside Chat: 3:00 pm ET
Location: New York

6th Annual Evercore ISI HealthCONx Conference
Date: Tuesday, November 28, 2023
Fireside Chat: 7:55 am ET
Location: Miami
Webcasts of the above presentations may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics’ website at View Source The Company will maintain archived replays of these webcasts on its website for 30 days.